DNA Methylation As a Mediator of the Association Between Prenatal Adversity and Risk Factors for Metabolic Disease in Adulthood
Authors
Affiliations
Although it is assumed that epigenetic mechanisms, such as changes in DNA methylation (DNAm), underlie the relationship between adverse intrauterine conditions and adult metabolic health, evidence from human studies remains scarce. Therefore, we evaluated whether DNAm in whole blood mediated the association between prenatal famine exposure and metabolic health in 422 individuals exposed to famine in utero and 463 (sibling) controls. We implemented a two-step analysis, namely, a genome-wide exploration across 342,596 cytosine-phosphate-guanine dinucleotides (CpGs) for potential mediators of the association between prenatal famine exposure and adult body mass index (BMI), serum triglycerides (TG), or glucose concentrations, which was followed by formal mediation analysis. DNAm mediated the association of prenatal famine exposure with adult BMI and TG but not with glucose. DNAm at (cg09349128), a gene involved in energy metabolism, mediated 13.4% [95% confidence interval (CI), 5 to 28%] of the association between famine exposure and BMI. DNAm at six CpGs, including (cg19693031), influencing β cell function, and (cg07397296), affecting lipid metabolism, together mediated 80% (95% CI, 38.5 to 100%) of the association between famine exposure and TG. Analyses restricted to those exposed to famine during early gestation identified additional CpGs mediating the relationship with TG near (glycolysis) and (adipogenesis). DNAm at the CpGs involved was associated with gene expression in an external data set and correlated with DNAm levels in fat depots in additional postmortem data. Our data are consistent with the hypothesis that epigenetic mechanisms mediate the influence of transient adverse environmental factors in early life on long-term metabolic health. The specific mechanism awaits elucidation.
Sex-specific role of epigenetic modification of a leptin upstream enhancer in adipose tissue.
Muller L, Oelkrug R, Mittag J, Hoffmann A, Ghosh A, Noe F Clin Epigenetics. 2025; 17(1):21.
PMID: 39934931 PMC: 11816557. DOI: 10.1186/s13148-025-01830-2.
Xu Z, Li C, Chi S, Yang T, Wei P Biostatistics. 2024; 26(1).
PMID: 39412139 PMC: 11823199. DOI: 10.1093/biostatistics/kxae037.
Lin C, Cai X, Li Z, Lv F, Yang W, Ji L J Glob Health. 2024; 14:04167.
PMID: 39302069 PMC: 11414423. DOI: 10.7189/jogh.14.04167.
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer.
Wahab M, Del Gaudio N, Gargiulo B, Quagliariello V, Maurea N, Nebbioso A Cancers (Basel). 2024; 16(17).
PMID: 39272883 PMC: 11394081. DOI: 10.3390/cancers16173026.
Li C, O Grada C, Lumey L BMJ Glob Health. 2024; 9(8).
PMID: 39209764 PMC: 11367352. DOI: 10.1136/bmjgh-2024-015355.